Sequence Similarity Clusters for the Entities in PDB 1NGQ

Entity #1 | Chains: L
N1G9 (IGG1-LAMBDA) protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 4 8 7066
95 % 14 39 510 Flexibility: Low
Max RMSD: 8.9, Avg RMSD: 2.4
PDBFlex
90 % 17 45 469
70 % 1066 2538 1
50 % 2185 5152 1
40 % 2512 5806 1
30 % 3061 7240 1
Entity #2 | Chains: H
N1G9 (IGG1-LAMBDA) protein, length: 222 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 46149
95 % 1 8 10218 Flexibility: Low
Max RMSD: 3.6, Avg RMSD: 2.2
PDBFlex
90 % 11 39 734
70 % 1057 2497 2
50 % 2186 5152 1
40 % 2513 5806 1
30 % 3062 7240 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 5YD4 1 A, C, E, G scFv 4B08 10090
32 5YD3 1 A, C, E, G scFv 4B08 10090
33 2XT1 2 B CAMELID VHH 9 30538
34 5UD9 1 H Fab heavy chain 9606
35 5UD9 2 L Light chain 9606
36 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
37 4P48 1 A Antibody scFv 180 9031
38 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
39 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
40 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
41 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
42 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
43 5J1S 3 C VHH domain BS-2 30538
44 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
45 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
46 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
47 5J1T 3 C VHH domain BS-2 30538
48 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
49 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
50 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
51 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
52 4XCF 1 L 4E10 Fab light chain 9606
53 4XCF 2 H 4E10 Fab heavy chain 9606
54 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
55 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
56 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
57 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
58 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
59 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
60 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
61 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
62 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
63 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
64 5X08 1 H Fab 4E10 Heavy chain 9606
65 5X08 2 L Fab 4E10 Light chain 9606
66 2X1O 1 A, B GELSOLIN NANOBODY 9844
67 4QGY 1 A, B nanobody n25, VH domain 9844
68 5C2B 1 H scFv 3B4 heavy chain 9606
69 4XAW 1 L 4E10 Fab light chain 9606
70 4XAW 2 H 4E10 Fab heavy chain 9606
71 5VNV 1 A Nb.b201 32630
72 4P49 1 A Antibody scFv B8 9031
73 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
74 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
75 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
76 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
77 5DXW 1 A PD-L1 nanobody 10090
78 5UCB 1 H Fab Heavy Chain 9606
79 5UCB 2 L Fab Light Chain 9606
80 2VXV 1 H HUMAN IGG ABT-325 9606
81 2VXV 2 L HUMAN IGG ABT-325 9606
82 4N9O 2 B Nanobody Nb484 Nb484 9844
83 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
84 4GXV 1 H, I Antibody 1F1, heavy chain 9606
85 4GXV 2 L, M Antibody 1F1, light chain 9606
86 2VXT 1 H MURINE IGG 125-2H 10090
87 2VXT 3 L MURINE IGG 125-2H 10090
88 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
89 1T2J 1 A M12-Variable Heavy domain 9606
90 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
91 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
92 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
93 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
94 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
95 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
96 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
97 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
98 5W24 1 L 5C4 Fab Light Chain 10090
99 5W24 2 H 5C4 Fab Heavy Chain 10090
100 4HPY 1 H CH59 Fab heavy chain 9606
101 4HPY 2 L CH59 Fab light chain 9606
102 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
103 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
104 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
105 5VM6 1 A single domain camelid nanobody VHH T10 9844
106 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
107 4JG1 1 L Fab light chain 9606
108 4JG1 2 H Fab heavy chain 9606
109 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
110 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
111 4KML 2 B Nanobody 9844
112 5VF2 1 A scFv 2D10 10090
113 5I8C 1 A VRC34.01 Fab heavy chain 9606
114 5I8C 2 B VRC34.01 Fab light chain 9606
115 4O5L 1 L Fab F045-092 light chain 9606
116 4O5L 2 H Fab F045-092 heavy chain 9606
117 5MYX 1 A, C Fab c#24 light chain 10090
118 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
119 4Z9K 2 B VHH2(F5) antibody 30538
120 3IFL 1 L 12A11 FAB antibody light chain 10090
121 3IFL 2 H 12A11 FAB antibody heavy chain 10090
122 5WK2 1 L M116 LIGHT CHAIN 9606
123 5WK2 2 H M116 HEAVY CHAIN FD 9606
124 3PP4 1 H GA101 Fab heavy chain 10090
125 3PP4 2 L GA101 Fab light chain 10090
126 3KDM 1 A, L Immunoglobulin light chain 9606
127 3KDM 2 B, H Immunoglobulin heavy chain 9606
128 5NIV 1 A Light chain of 5D3 Fab 10090
129 5NIV 2 B Heavy chain of 5D3 Fab 10090
130 5N4J 1 L LIGHT CHAIN 9606
131 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
132 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
133 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
134 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
135 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
136 5X4G 1 A 6H8 Fab heavy chain 10090
137 5X4G 2 B 6H8 Fab light chain 10090
138 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
139 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
140 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
141 4PTU 1 A Antibody pn132p2C05, light chain 9606
142 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
143 4TPR 1 L If kappa light chain 10090
144 4TPR 2 H Fab heavy chain 10090
145 5LMW 1 A Nanobody 9844
146 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
147 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
148 3IFN 1 H 12A11 FAB antibody heavy chain 10090
149 3IFN 2 L 12A11 FAB antibody light chain 10090
150 5U3P 1 H DH511.4 Fab Heavy Chain 9606
151 5U3P 2 L DH511.4 Fab Light Chain 9606
152 6BLA 1 H AMM01 Fab Heavy chain 9606
153 6BLA 2 L AMM01 Fab Light chain 9606
154 5NM0 1 A, B, C, D Nb36 9844
155 4TOY 1 H 35O22 Fab Heavy chain 9606
156 4TOY 2 L 35O22 Fab Light chain 9606
157 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
158 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
159 3NPS 2 B S4 FAB HEAVY CHAIN 9606
160 3NPS 3 C S4 FAB LIGHT CHAIN 9606
161 5I4F 1 A scFv 2D10 10090
162 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
163 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
164 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
165 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
166 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
167 5WN9 1 H scFv 2D10 9606
168 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
169 4XC3 1 L 4E10 Fab light chain 9606
170 4XC3 2 H 4E10 Fab heavy chain 9606
171 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
172 4PPT 1 A Engineered single domain VHH antibody 9844
173 3R0M 1 A, B Llama VHH A12 9844
174 4M5Y 1 H, I Fab 5J8 heavy chain 9606
175 4M5Y 2 L, M Fab 5J8 light chain 9606
176 4TQE 1 L If kappa light chain 10090
177 4TQE 2 H Fab heavy chain 10090
178 3ZKQ 2 D XA4813 9844
179 4I13 2 B Protein ca1697 (nanobody) 9844
180 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
181 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
182 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
183 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
184 5C2U 1 B Nanobody Nanobody 9838
185 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
186 5VSI 2 L CH1/Ckappa Fab light chain 9606
187 1XFP 1 A heavy chain antibody VHH domain 9838
188 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
189 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
190 5JXA 1 H VRC03 Heavy chain 9606
191 5JXA 2 L VRC03 Light chain 9606
192 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
193 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
194 4POY 1 A VHH-metal 9844
195 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
196 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
197 5NLW 1 A nanobody Nb36 9844
198 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
199 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
200 3NTC 1 L Fab light chain 10090
201 3NTC 2 H Fab heavy chain 10090
202 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
203 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
204 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
205 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
206 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
207 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
208 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
209 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
210 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
211 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
212 6BE3 1 H Fab (F598) Heavy Chain 9606
213 6BE3 2 L Fab (F598) Light Chain 9606
214 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
215 3G9A 2 B Minimizer 9838
216 4NWU 1 H APE1551 Ab Fab heavy chain 9606
217 4NWU 2 L APE1551 Ab Fab light chain 9606
218 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
219 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
220 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
221 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
222 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
223 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
224 5EWI 1 H VRC38.01 Heavy Chain 9606
225 5EWI 2 L VRC38.01 Light Chain 9606
226 5E2W 1 L AT8 LIGHT CHAIN 10090
227 5E2W 2 H AT8 HEAVY CHAIN 10090
228 5MYK 1 A Fab c#17 light chain 10090
229 5MYK 2 B Fab c#17 heavy chain 10090
230 4NZR 1 H PGT135 heavy chain Fab 9606
231 4NZR 2 L PGT135 light chain Fab 9606
232 5MYO 1 A, C Fab c#6 light chain 10090
233 5MYO 2 B, D Fab c#6 heavy chain 10090
234 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
235 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
236 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
237 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
238 5UEL 1 H 354NC102 Fab Heavy Chain 9606
239 5UEL 2 L 354NC102 Fab Light Chain 9606
240 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
241 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
242 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
243 2P43 2 B ANTIBODY CAB-RN05 9838
244 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
245 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
246 5E2V 1 L AT8 LIGHT CHAIN 10090
247 5E2V 2 H AT8 HEAVY CHAIN 10090
248 4KRN 1 A Nanobody/VHH domain EgA1 9844
249 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
250 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
251 4GFT 2 B Nanobody 9844
252 4TVS 2 a, b VHH Domain BS-1 30538
253 4W6Y 2 B Nanobody NbFedF9 9844
254 6EZW 1 B VHH antibody BCD090-M2 9844
255 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
256 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
257 5JUE 1 L light chain of UIC2 Fab 10090
258 5JUE 2 H heavy chain of UIC2 Fab 10090
259 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
260 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
261 1UAC 2 H Ig VH,anti-lysozyme 10090
262 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
263 5JR1 1 H 10E8 heavy chain 9606
264 5JR1 2 L 10E8 mature light chain 9606
265 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
266 5VF6 1 A single chain variable fragment 9031
267 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
268 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
269 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
270 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
271 5OB5 2 H fAb Heavy chain 9606
272 5OB5 3 L fAb Light chain 9606
273 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
274 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
275 5I66 1 A 8B6 antibody, heavy chain 10090
276 5I66 2 B 8B6 antibody, light chain 10090
277 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
278 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
279 3QQ9 1 C, L 101F LIGHT CHAIN 10090
280 3QQ9 2 D, H 101F HEAVY CHAIN 10090
281 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
282 5TKK 3 L mouse antibody vFP5.01 light chain 10090
283 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
284 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
285 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
286 5W6C 1 H UCA Fab heavy chain 9606
287 5W6C 2 L UCA Fab light chain 9606
288 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
289 5I1K 1 L FAB LIGHT CHAIN 9606
290 5I1K 2 H FAB HEAVY CHAIN 9606
291 3OZ9 1 L Fab NC-1 kappa light chain 10090
292 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
293 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
294 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
295 5V7U 1 L CBTAU-22.1 Fab light chain 9606
296 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
297 5UEA 1 A, H Fab Heavy Chain 9606
298 5UEA 3 B, L Fab Light Chain 9606
299 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
300 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
301 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
302 3G5Y 1 A 175 light chain 10090
303 3G5Y 2 B 175 heavy chain 10090
304 5O02 2 C Nanobody (VHH) Nano-4 30538
305 5NMV 1 L Fab light chain 10088
306 5NMV 2 H Fab heavy chain 10088
307 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
308 4N8C 2 L, M Light chain of monoclonal antibody 10090
309 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
310 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
311 4HGW 1 A Antibody Fab fragment, light chain 10090
312 4HGW 2 B Antibody Fab fragment, heavy chain 10090
313 1NLB 1 L antibody 19D9D6 light chain 10090
314 1NLB 2 H antibody 19D9D6 heavy chain 10090
315 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
316 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
317 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
318 3VFG 1 L 3F8 Light Chain 10090
319 3VFG 2 H 3F8 Heavy Chain 10090
320 4X7F 2 C, D Nano-25 Nanobody 30538
321 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
322 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
323 3QRG 1 L Fab light chain 9606
324 3QRG 2 H Fab heavy chain Fd fragment 9606
325 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
326 5M6A 1 A, B, C, D Bence-Jones light chain 9606
327 4LLY 2 B, D light chain Clambda 9606
328 4LGR 2 B Camelid nanobody (VHH3) 30538
329 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
330 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
331 5EZI 1 H Fab c12 heavy chain 9606
332 5EZI 2 L Fab c12 Light chain 9606
333 4K23 1 H anti-uPAR antibody, heavy chain 10090
334 4K23 2 L anti-uPAR antibody, light chain 10090
335 5J57 2 B VHH single chain antibody V5E1 30538
336 3NCJ 1 L Fab15 Mut8 light chain 9606
337 3NCJ 2 H Fab15 Mut8 heavy chain 9606
338 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
339 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
340 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
341 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
342 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
343 5W05 1 L M59 FAB LIGHT CHAIN 10090
344 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
345 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
346 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
347 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
348 5OMM 2 C Nanobody (VHH) Nano-14 30538
349 5E03 1 A mouse CTLA-4 nanobody 10090
350 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
351 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
352 4M61 1 A, C Fab A52 light chain 10090
353 4M61 2 B, D Fab A52 heavy chain 10090
354 5LZ0 1 A, B PorM nanobody 9844
355 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
356 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
357 1UM5 1 L Antibody 21H3 L chain 10090
358 1UM5 2 H Antibody 21H3 H chain 10090
359 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
360 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
361 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
362 4NWT 1 L APE1531 Ab Fab light chain 9606
363 4NWT 2 H APE1531 Ab Fab heavy chain 9606
364 3WHX 1 A mAb Fab H fragment 10090
365 3WHX 2 B mAb Fab L fragment 10090
366 3NA9 1 L Fab15 light chain 9606
367 3NA9 2 H Fab15 heavy chain 9606
368 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
369 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
370 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
371 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
372 4LRI 1 A, B MSL-109 Light Chain 9606
373 4LRI 2 C, P MSL-109 Heavy Chain 9606
374 2XXC 1 B CAMELID VHH 9 30538
375 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
376 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
377 4JN2 1 A, L anti dabigatran Fab 10090
378 4JN2 2 B, H anti dabigatran Fab 10090
379 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
380 4XBE 2 H 4E10 Fab heavy chain 9606
381 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
382 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
383 6BE2 1 H Fab (F598) Heavy Chain 9606
384 6BE2 2 L Fab (F598) Light Chain 9606
385 3QYC 1 A, B VH domain of IgG molecule 9606
386 4JFZ 1 L Fab light chain 9606
387 4JFZ 2 H Fab heavy chain 9606
388 5VAK 2 B Nb914 Nanobody 9844
389 3WIF 1 A mAb Fab H fragment 10090
390 3WIF 2 B mAb Fab L fragment 10090
391 5U6A 1 A Light Chain 9606
392 5U6A 2 B Heavy Chain 9606
393 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
394 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
395 3MBX 1 L X836 LIGHT CHAIN 10090
396 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
397 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
398 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
399 2XXM 2 B CAMELID VHH 9 30538
400 6APC 1 H Epididymis luminal protein 214 9606
401 6APC 2 L IGL@ protein 9606
402 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
403 4HHA 1 A Fab KE5 Fab fragment KE5 9606
404 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
405 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
406 4RGO 2 H 14G8 heavy chain Fab 10090
407 4RGO 3 L 14G8 light chain Fab 10090
408 5GRY 1 A, G diabody 9606
409 5UEK 2 H Fab 12E Heavy Chain 9606
410 5UEK 3 L Fab 12E Light Chain 9606
411 3NAA 1 L Fab15 Mut5 light chain 9606
412 3NAA 2 H Fab15 Mut5 heavy chain 9606
413 1Q0X 1 L Fab 9B1, light chain 10090
414 1Q0X 2 H Fab 9B1, heavy chain 10090
415 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
416 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
417 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
418 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
419 5JDS 1 B Nanobody 9835
420 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
421 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
422 5IK3 2 B, D 1E03 Fab fragment light chain 9606
423 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
424 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
425 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
426 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
427 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
428 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
429 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
430 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
431 4WUK 1 H CH65 heavy chain 9606
432 4WUK 2 L CH65 light chain 9606
433 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
434 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
435 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
436 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
437 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
438 5JOP 1 D, L Fab 14.22 light chain 10090
439 5JOP 2 E, H Fab14.22 heavy chain 10090
440 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
441 4HPO 1 H CH58 Fab heavy chain 9606
442 4HPO 2 L CH58 Fab light chain 9606
443 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
444 5UKN 2 L DH522UCA Fab fragment light chain 9544
445 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
446 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
447 5L21 2 B VHH-C2 30538
448 5IT2 1 H heavy chain 9606
449 5IT2 2 L light chain 9606
450 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
451 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
452 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
453 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
454 5FWO 1 A NANOBODY 9844
455 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
456 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
457 5MO3 3 L Fab of monoclonal antibody, light chain 10090
458 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
459 5GZ0 1 A, C FM329 light chain 1383439
460 5GZ0 2 B, D FM329 heavy chain 1383439
461 3B9V 1 A, B, C, D heavy chain variable domain 9606
462 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
463 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
464 6BQB 1 L MGG4 Fab light chain 9606
465 6BQB 2 H MGG4 Fab heavy chain 9606
466 4PUB 1 H DX-2930 HEAVY CHAIN 9606
467 4PUB 2 L DX-2930 LIGHT CHAIN 9606
468 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
469 6B14 2 L Light chain of Fab BL3-6S97N 10090
470 5N88 1 A, H VH59 antibody 9606
471 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
472 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
473 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
474 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
475 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
476 5GS3 1 A, H diabody protein 9606
477 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
478 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
479 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
480 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
481 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
482 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
483 5VKD 2 H Fab Heavy Chain 9606
484 5VKD 3 L Fab light chain 9606
485 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
486 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
487 5XHG 1 A, C polypeptide(L) 562
488 5XHG 2 B, D polypeptide(H) 562
489 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
490 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
491 3UYR 1 H antibody Fab heavy chain 10090
492 3UYR 2 L antibody Fab light chain 10090
493 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
494 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
495 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
496 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
497 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
498 3OAZ 2 K, L Fab 2G12, light chain 9606
499 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
500 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
501 1ZAN 1 L Fab AD11 Light Chain 10116
502 1ZAN 2 H Fab AD11 Heavy Chain 10116
503 4N0Y 1 H IGH526 Heavy Chain 9606
504 4N0Y 2 L IGH526 Light Chain 9606
505 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
506 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
507 5MTH 1 A, H antibody Fab heavy chain 10090
508 5MTH 2 B, L antibody Fab light chain 10090
509 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
510 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
511 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
512 1RZF 1 L Fab E51 light chain 9606
513 1RZF 2 H Fab E51 heavy chain 9606
514 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
515 4KTE 2 L GE148 Light Chain Fab 9544
516 5I8O 1 H HMM5 antibody heavy chain 9606
517 5I8O 2 L HMM5 antibody light chain 9606
518 4OUO 1 A anti Bla g 1 scFv 9031
519 4JG0 1 L Fab light chain 9606
520 4JG0 2 H Fab heavy chain 9606
521 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
522 4YGV 2 B, L aDabi-Fab2a light chain 9606
523 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
524 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
525 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
526 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
527 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
528 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
529 3EO0 1 A, C GC-1008 Fab Light Chain 10090
530 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
531 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
532 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
533 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
534 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
535 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
536 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
537 4POU 2 B VHH Antibody 9844
538 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
539 4FQI 3 H antibody CR9114 heavy chain Fab 9606
540 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
541 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
542 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
543 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
544 4JHA 2 L D25 light chain 9606
545 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
546 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
547 4PTT 1 A Antibody pn132p2C05, light chain 9606
548 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
549 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
550 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
551 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
552 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
553 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
554 2P42 2 B, D ANTIBODY CAB-RN05 9838
555 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
556 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
557 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
558 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
559 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
560 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
561 4DGV 1 H HCV1 Heavy Chain Fab 9606
562 4DGV 2 L HCV1 Light Chain 9606
563 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
564 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
565 5TH2 1 A, C cetuximab Fab, light chain 10090
566 5TH2 2 B, D cetuximab Fab, heavy chain 10090
567 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
568 5I8K 1 L HHH1 Fab Light chain 9606
569 5I8K 2 H HHH1 Fab Heavy chain 9606
570 4QLR 1 A, B Llama nanobody n02 VH domain 9844
571 5J56 2 B VHH single chain antibody V1C7 30538
572 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
573 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
574 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
575 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
576 1YNL 1 L Ig gamma light chain 10090
577 1YNL 2 H Ig gamma heavy chain 10090
578 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
579 5EPM 2 B, F Antibody Fab fragment light chain 10090
580 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
581 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
582 3UMT 1 A scFv heavy chain and light chain 10090
583 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
584 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
585 4NUJ 1 A PGT152 light chain 9606
586 4NUJ 2 B PGT152 heavy chain 9606
587 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
588 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
589 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
590 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
591 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
592 3U2S 2 B, L PG9 light chain 9606
593 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
594 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
595 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
596 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
597 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
598 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
599 4NUG 1 L PGT151 light chain 9606
600 4NUG 2 H PGT151 heavy chain 9606
601 3IU4 1 H chP3 Fab heavy chain 10090
602 3IU4 2 L chP3 Fab light chain 10090
603 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
604 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
605 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
606 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
607 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
608 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
609 1P7K 1 A, L antibody light chain FAB 10090
610 1P7K 2 B, H antibody heavy chain FAB 10090
611 4NBX 2 B A20.1 VHH 9844
612 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
613 3RVV 2 C 4C1 - light chain 10090
614 3RVV 3 D 4C1 - heavy chain 10090
615 4HEP 2 G vHH17 domain 9844
616 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
617 3P0Y 2 H Fab DL11 heavy chain 9606
618 3P0Y 3 L Fab DL11 light chain 9606
619 4NPY 1 A, L germline PGT121 light chain Fab 9606
620 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
621 6ANA 2 H LL2 Fab Heavy Chain 10090
622 6ANA 3 L LL2 Fab Light Chain 10090
623 5IBU 1 B, L 6652 Light Chain 9606
624 5IBU 2 G, H 6652 Heavy Chain 9606
625 5VPL 2 C 4C1 - LIGHT CHAIN 10090
626 5VPL 3 D 4C1 - HEAVY CHAIN 10090
627 6AOD 1 A FXIa Antibody FAB Light Chain 9606
628 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
629 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
630 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
631 2YPV 2 H FAB 12C1 10090
632 2YPV 3 L FAB 12C1 10090
633 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
634 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
635 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
636 4JY5 1 L PGT122 light chain Fab 9606
637 4JY5 2 H PGT122 heavy chain Fab 9606
638 6ELE 1 A, H fAB heavy chain 9606
639 6ELE 2 B, L fAB light chain 9606
640 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
641 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
642 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
643 6B5R 1 H CIS42 Fab Heavy chain 9606
644 6B5R 2 L CIS42 Fab Light chain 9606
645 5IML 2 B Nanobody 9835
646 3NAC 1 L Fab15 Mut7 light chain 9606
647 3NAC 2 H Fab15 Mut7 heavy chain 9606
648 3A6C 2 H IG VH, anti-lysozyme 10090
649 2DQD 2 H Ig VH,anti-lysozyme 10090
650 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
651 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
652 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
653 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
654 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
655 1Q72 1 L Fab M82G2, Light chain 10090
656 1Q72 2 H Fab M82G2, Heavy chain 10090
657 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
658 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
659 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
660 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
661 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
662 4YHO 1 H aDabi-Fab3 heavy chain 9606
663 4YHO 2 L aDabi-Fab3 light chain 9606
664 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
665 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
666 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
667 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
668 4DGY 1 H HCV1 Heavy Chain Fab 9606
669 4DGY 2 L HCV1 Light Chain 9606
670 3A67 2 H IG VH, anti-lysozyme 10090
671 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
672 5EN2 1 A GD01 heavy chain 10090
673 5EN2 2 B GD01 light chain 10090
674 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
675 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
676 1J1X 2 H Ig VH,anti-lysozyme 10090
677 5M2J 2 D Anti-(ED-B) scFV 9606
678 3MXW 2 L 5E1 light chain 9606
679 3MXW 3 H 5E1 heavy chain 9606
680 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
681 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
682 2DQC 2 H Ig VH,anti-lysozyme 10090
683 1J1O 2 H Ig VH,anti-lysozyme 10090
684 3EO9 1 L Efalizumab Fab fragment, light chain 9606
685 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
686 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
687 4M62 2 H, I GEP2 FV heavy chain 9606
688 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
689 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
690 5IVO 1 A BC2-nanobody 30538
691 1J1P 2 H Ig VH,anti-lysozyme 10090
692 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
693 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
694 4NBZ 2 B, D A26.8 VHH 9844
695 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
696 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
697 5WUV 1 L light chain 9606
698 5WUV 2 H heavy chain 9606
699 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
700 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
701 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
702 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
703 5AYU 2 H Ig VH,anti-lysozyme 10090
704 4JM4 1 H PGT 135 Heavy Chain Fab 9606
705 4JM4 2 L PGT 135 Light Chain Fab 9606
706 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
707 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
708 3A6B 2 H IG VH, anti-lysozyme 10090
709 2DQJ 2 H Ig VH,anti-lysozyme 10090
710 5F21 2 B nanobody MU375 9844
711 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
712 6B0G 1 C 1245 Antibody, Light Chain 9606
713 6B0G 2 D 1245 Antibody, Heavy Chain 9606
714 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
715 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
716 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
717 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
718 6D0X 1 A 2140 Antibody, heavy chain 9606
719 6D0X 2 B 1210 Antibody, light chain 9606
720 2P44 2 B ANTIBODY CAB-RN05 9838
721 6BE4 1 H Fab (F598) Heavy Chain 9606
722 6BE4 2 L Fab(F598) Light Chain 9606
723 5TPP 1 L DH270.5 Fab heavy chain 9606
724 5TPP 2 H DH270.5 Fab light chain 9606
725 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
726 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
727 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
728 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
729 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
730 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
731 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
732 5TP3 1 A, B F-VHH-4 9844
733 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
734 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
735 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
736 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
737 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
738 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
739 5TL5 1 L M2177 LIGHT CHAIN 10090
740 5TL5 2 H M2177 HEAVY CHAIN 10090
741 2FX7 1 L Fab 4E10 Light Chain 9606
742 2FX7 2 H Fab 4E10 Heavy Chain 9606
743 5Y9K 1 L belimumab light chain 9606
744 5Y9K 2 H belimumab heavy chain 9606
745 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
746 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
747 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
748 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
749 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
750 4LHJ 2 B Camelid antibody 30538
751 3WFH 1 A mAb Fab H fragment 10090
752 3WFH 2 B mAb Fab L fragment 10090
753 4BEL 2 D, E XA4813 9844
754 5M7Q 1 A, B Nanobody NbD2 9838
755 5H8D 1 A VHH nanobody 9844
756 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
757 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
758 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
759 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
760 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
761 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
762 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
763 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
764 3DUR 2 B, D Ig-like protein 10090
765 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
766 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
767 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
768 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
769 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
770 5HI4 3 D, L CAT-2000 FAB light chain 9606
771 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
772 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
773 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
774 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
775 3RVW 2 C 4C1 - light chain 10090
776 3RVW 3 D 4C1 - heavy chain 10090
777 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
778 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
779 5XKU 2 B HNIgGA6 light chain 9606
780 5XKU 3 C HNIgGA6 heavy chain 9606
781 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
782 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
783 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
784 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
785 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
786 5HI5 3 D, L CAT-2000 light chain 9606
787 5JO5 1 A, C, E, H 10E8 gHV 9606
788 5JO5 2 B, D, F, L 10E8 gLV 9606
789 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
790 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
791 2XV6 2 B, D CAMELID VHH 9 30538
792 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
793 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
794 5CCK 2 L Antibody 3BC315 Fab light chain 9606
795 5VM0 1 A, B Camelid Nanobody VHH T9 9844
796 5I76 1 A, C FM318_light_chain 1383439
797 5I76 2 B, D FM318_heavy_cahin 1383439
798 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
799 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
800 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
801 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
802 5I18 1 L FAB LIGHT CHAIN 9606
803 5I18 2 H FAB HEAVY CHAIN 9606
804 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
805 4JN1 2 L anti-dabigatran Fab1, light chain 10090
806 4ZG1 1 A, B, C, D, E, F NB17 9844
807 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
808 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
809 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
810 4G5Z 2 L canakinumab antibody fragment light chain 9606
811 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
812 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
813 2OK0 2 L Fab ED10 light chain 10090
814 2OK0 3 H Fab ED10 heavy chain 10090
815 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
816 3SOB 1 L antibody light chain 9606
817 3SOB 3 H antibody heavy chain 9606
818 6B5M 1 H CIS43 Fab Heavy chain 9606
819 6B5M 2 L CIS43 Fab Light chain 9606
820 4I1N 2 B Protein ca1697 (nanobody) 9844
821 5AWN 1 H Heavy chain of 3BC176 Fab 9606
822 5AWN 2 L Light chain of 3BC176 Fab 9606
823 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
824 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
825 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
826 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
827 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
828 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
829 5DR5 2 L AbD09097 Fab light chain 9606
830 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
831 2IH3 1 A FAB Heavy Chain 10090
832 2IH3 2 B FAB Light Chain 10090
833 4KQ3 1 L CNTO3186 light chain Fab 9606
834 4KQ3 2 H CNTO3186 heavy chain Fab 9606
835 6F0D 1 A, B VHH antibody BCD090-M2 9844
836 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
837 6AQ7 3 L POM6 FAB light CHAIN 10090
838 4JFX 1 A, L Fab light chain 9606
839 4JFX 2 B, H Fab heavy chain 9606
840 3SGE 1 I, L Light Chain 10090
841 3SGE 2 H, J Heavy Chain 10090
842 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
843 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
844 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
845 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
846 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
847 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
848 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
849 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
850 5FHB 1 H Antibody 100 Fab heavy chain 9606
851 5FHB 2 L Antibody 100 Fab light chain 9606
852 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
853 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
854 1JGU 1 L Antibody Light Chain 10090
855 1JGU 2 H Antibody Heavy Chain 10090
856 4I77 1 H Lebrikizumab heavy chain Fab 9606
857 4I77 2 L Lebrikizumab light chain Fab 9606
858 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
859 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
860 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
861 4O4Y 2 H 2095-2 heavy chain 9986
862 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
863 5OBF 1 H fAb Heavy chain 10090
864 5OBF 2 L fAb Light chain 10090
865 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
866 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
867 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
868 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
869 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
870 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
871 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
872 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
873 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
874 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
875 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
876 4GLR 3 I, K anti-ptau light chain light chain 9031
877 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
878 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
879 4HJG 1 A Trastuzumab light chain 9606
880 4HJG 2 B Trastuzumab heavy chain 9606
881 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
882 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
883 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
884 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
885 5I30 1 L Fab PL-2 light chain 10090
886 5I30 2 H Fab PL-2 heavy chain 10090
887 4W6X 2 B Nanobody NbFedF7 9844
888 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
889 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
890 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
891 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
892 3FN0 1 L Fab Z13e1 light chain 9606
893 3FN0 2 H Fab Z13e1 heavy chain 9606
894 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
895 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
896 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
897 4YHI 2 B, L aDabi-Fab2a light chain 9606
898 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
899 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
900 4OSU 1 H SM5-1 Fab Heavy Chain 9606
901 4OSU 2 L SM5-1 Fab Light Chain 9606
902 5JA9 2 A, B Nanobody 6 9844
903 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
904 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
905 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
906 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
907 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
908 1T2Q 1 L Fab NNA7 Heavy Chain 10090
909 1T2Q 2 H Fab NNA7 Light Chain 10090
910 6ELJ 1 A, H fAB heavy chain 9606
911 6ELJ 2 B, L fAB light chain 9606
912 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
913 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
914 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
915 4MAU 1 L C2244 light chain SEE REMARK 999 10090
916 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
917 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
918 3LEX 2 B, L 11f10 Antibody Light Chain 10090
919 6B0W 1 L 1710 antibody, light chain 9606
920 6B0W 2 H 1710 antibody, heavy chain 9606
921 1OP3 1 K, L FAB 2G12, light chain light chain 9606
922 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
923 1OP9 1 A HL6 camel VHH fragment 9838
924 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
925 5VH4 2 B, L Infliximab Fab Light Chain 10090
926 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
927 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
928 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
929 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
930 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
931 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
932 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
933 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
934 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
935 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
936 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
937 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
938 4LRN 1 H GEP 1 heavy chain 9606
939 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
940 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
941 4S11 1 A GELSOLIN NANOBODY 9844
942 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
943 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain